IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 297 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2,708,577 | +210.3% | 182,765 | +871.0% | 0.01% | +550.0% |
| Q4 2020 | $873,000 | -15.3% | 18,822 | -39.9% | 0.00% | -33.3% |
| Q3 2020 | $1,031,000 | -44.5% | 31,307 | -53.7% | 0.00% | -50.0% |
| Q2 2020 | $1,856,000 | +34.7% | 67,602 | +47.0% | 0.01% | +100.0% |
| Q1 2020 | $1,378,000 | +10.6% | 46,000 | +2.2% | 0.00% | -40.0% |
| Q4 2019 | $1,246,000 | -22.2% | 45,000 | -48.9% | 0.01% | -16.7% |
| Q3 2019 | $1,602,000 | -37.8% | 88,000 | -16.2% | 0.01% | -40.0% |
| Q2 2019 | $2,575,000 | +185.2% | 105,000 | +10.5% | 0.01% | +150.0% |
| Q1 2019 | $903,000 | +785.3% | 95,000 | +1087.5% | 0.00% | – |
| Q2 2018 | $102,000 | – | 8,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 19,997,103 | $90,986,819 | 11.15% |
| MPM BioImpact LLC | 3,287,397 | $14,957,656 | 3.99% |
| Perceptive Advisors | 11,962,938 | $54,431,367 | 1.82% |
| CM Management, LLC | 200,000 | $910,000 | 0.97% |
| Velan Capital Investment Management LP | 250,000 | $1,137,500 | 0.92% |
| Opaleye Management Inc. | 610,000 | $2,775,500 | 0.90% |
| Boxer Capital, LLC | 3,705,133 | $16,858,355 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 985,000 | $4,481,750 | 0.87% |
| Parametrica Management Ltd | 95,400 | $434,070 | 0.73% |
| 683 Capital Management, LLC | 2,050,000 | $9,327,501 | 0.72% |